KYORIN Holdings, Inc. takes on the role, as the controlling company, as being responsible for the business strategies of the overall group. By effectively allocating and utilizing its managerial resources, KYORIN will draw out the strengths of the entire group and endeavor to boost the group's consolidated result.
Group Structural Diagram
Major Subsidiaries and Affiliates
Consolidated subsidiaries
KYORIN Pharmaceutical Co., Ltd.
| Capital | 4,317 million yen (Percentage of ownership: 100%) |
|---|---|
| Head Office | Ochyanomizu Sola City 16F, Kanda Surugadai 4-6, Chiyoda-ku, Tokyo 101-8311 Japan |
| Operations | Manufacture and sales of prescription medicines and quasi-drugs, diagnostics and industrial chemical |
| Website | http://www.kyorin-pharm.co.jp/en/ |
KYORIN Rimedio Co., Ltd.
| Capital | 1,200 million yen (Percentage of ownership: 100%) |
|---|---|
| Head Office | 287-1, Shimocho Moroe-cho, Kanazawa City, Ishikawa Prefecture 920-0017 |
| Operations | Manufacture and sales of prescription medicines and quasi-drugs, diagnostics and industrial chemical |
| Website | http://www.kyorin-rmd.co.jp/ |
KYORIN Pharmaceutical Group Facilities Co.,Ltd.
| Capital | 450million yen (Percentage of ownership: 100%) |
|---|---|
| Head Office |
Ochyanomizu Sola City 16F, Kanda Surugadai 4-6, Chiyoda-ku, Tokyo 101-8311 Japan |
| Operations | Manufacture, sales of prescription medicines |
KYORIN Pharmaceutical Subsidiaries
Kyorin Europe GmbH
| Capital | 50,000 EURO (Percentage of ownership: 100%) |
|---|---|
| Head Office | Kaiserstrasse 8, 60311 Frankfurt am Main, Germany |
| Operations | Research and analysis of other companies’ technologies and collection of information concerning clinical trials |
ActivX Biosciences, Inc.
| Capital | US$1 (Percentage of ownership: 100%) |
|---|---|
| Head Office | 11025 N. Torrey Pines Rd. La Jolla, California 92037, United States |
| Operations | Discovery and evaluation of candidate compounds |
Equity-Method Affiliates
Nippon Rika Co., Ltd.
| Capital | ¥411 million (Percentage of ownership: 29.9%) |
|---|---|
| Head Office | 2-2, Nihonbashi Honcho 4-chome, Chuo-ku, Tokyo 103-0023 |
| Operations | Production and sales of pharmaceuticals, reagents, intermediates and other products |